---
title: "Cathay Biotech authorizes its subsidiary for mutual guarantee, with a limit not exceeding 2 billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259364427.md"
description: "Shanghai Cathay Biotech Co., Ltd. announced that it has authorized its non-wholly-owned subsidiary to provide guarantees when applying for credit and during daily operations, with a limit not exceeding 2 billion yuan. Currently, the total amount of external guarantees provided by non-wholly-owned subsidiaries is 500 million yuan, all of which are inter-subsidiary guarantees, and there are no overdue or litigated guarantees. This authorization has been approved by the board of directors, the guarantee risk is controllable, and it does not harm the interests of the company and its shareholders"
datetime: "2025-09-29T13:51:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259364427.md)
  - [en](https://longbridge.com/en/news/259364427.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259364427.md)
generator: "portal-rs"
---

# Cathay Biotech authorizes its subsidiary for mutual guarantee, with a limit not exceeding 2 billion

Shanghai Cathay Biotech Co., Ltd. announced that in order to meet the development and operational needs of its non-wholly-owned subsidiaries, it authorizes them to provide guarantees when applying for credit and conducting daily operations with other non-wholly-owned subsidiaries. The total balance of guarantees during the authorization period shall not exceed 2 billion yuan, with the actual amount subject to contracts or approvals. As of the announcement date, the total external guarantees of non-wholly-owned subsidiaries amount to 500 million yuan, all of which are inter-subsidiary guarantees, with no overdue or litigation-related guarantees. The main guaranteed parties include Cathay Biomaterials Co., Ltd. and Cathay Biotechnology Co., Ltd., both of which have a debt-to-asset ratio not exceeding 70%. This authorization has been reviewed and approved by the board of directors and does not require shareholder meeting approval. The guarantee risk is controllable, and there is no situation that harms the interests of the company and its shareholders

### Related Stocks

- [688065.CN](https://longbridge.com/en/quote/688065.CN.md)

## Related News & Research

- [10:22 ETIndonesia's Institut Teknologi Bandung wins 2026 AAPG Imperial Barrel Award](https://longbridge.com/en/news/296369933.md)
- [Chugin Capital Partners’ investment head Ishimoto joins POTLUCK AWARD’26 final panel as judge](https://longbridge.com/en/news/296545904.md)
- [China's AMEC to Invest USD520 Million to Boost Chip Equipment Capacity at Lingang Plant](https://longbridge.com/en/news/296452430.md)
- [09:03 ETPlayOn Sports Brings the Nation's Top High School Football Games to Fans Nationwide with 2026 MaxPreps Game of the Week](https://longbridge.com/en/news/296621737.md)
- [DAZN becomes Indiana Pacers’ exclusive regional streaming partner for 2026-27 season](https://longbridge.com/en/news/296538501.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**